Expert insights on Pharma innovation, Biotech strategy and Medtech breakthroughs for life sciences professionals.
Our editorial framework examines what's happening now, why it matters and what to look for next across pharma, biotech and medtech.
The CDMO shift continues to accelerate as innovation and execution at scale become key advantages.
Operational resilience, speed to market and specialised capabilities are now critical to competitive differentiation.
Winners will invest in flexibility, innovation and deeper collaboration to stay ahead of patient needs.
What to Expect in the Next Issue of Industry Intelligence
The next wave of innovation in commercial and patient engagement.
Grateful to our Industry Intelligence partners whose insights and expertise shaped this section of the issue.
A practical route for molecules that struggle with oral delivery - It suitability is scorned early against the right physicochemical struggle with oral delivery criteria.